FAPOMED – Dispositivos Médicos, SA is pleased to invite all stakeholders and other interested parties to visit us at this year’s MEDICA – Leading International Trade Fair at our new stand and location: Hall 6 / H04.
See you on November the 14th!
It was last November that Fapomed was present at what is considered the largest medicine fair in the world, in Düsseldorf, Germany: MEDICA 2021.
Two years after last edition, we were together and in proximity, strengthening ties and contacts with our customers and partners.
To all who visited us we have to say: Thank you!
To those who didn’t had the opportunity to be with us this year we say: See you soon, we’ll be back in 2022.
Fapomed – In the Right Place When life is at risk
FAPOMED – Dispositivos Médicos, SA is pleased to invite all stakeholders and other interested parties to visit us at this year’s MEDICA – Leading International Trade Fair at our new stand and location: Hall 6 / A44.
Two years later since the last in-person edition, we will be again side by side, because that’s the only way we know how to be, in Proximity and in the Right Place when life is at risk.
See you on the 15th November!
It was last November that Fapomed was present at what is considered the largest medicine fair in the world, in Düsseldorf, Germany: MEDICA 2019.
After this presence, a result of hard work and commitment of a vast and multidisciplinary team, Fapomed thanks all those who, directly or indirectly, made those 4 days a huge success story, and allowed the recognition of customers, suppliers, and an entire medical community that once again valued Fapomed for Being in the Right Place.
Thank you all very much, and we look forward to see you again in 2020!
Fapomed will be present at next MEDICA Trade Fair 2019 in Düsseldorf, Germany, between November 18th and 21st.
Being this one the largest medical fair in the world, and where the largest and best medical exhibitors are present, Fapomed could not help but present itself to its counterparts, assuming once more to be in the right place when life is at risk.
It was on November 21st that CEO of Fapomed, Mr. Miguel Lopes da Cunha, participated in the “VIII Annual Conference of HCP (Health Cluster Portugal), entitled “Health in Portugal: building consensus for 2020 and beyond” .
The participation of the Administrator was attributed to the roundtable entitled “The Economy in Relation to Medical Care and Scientific Research”, moderated by João Almeida Lopes, Vice-President of HCP, and a panel composed by António Portela, CEO of Bial, Florian Ibe, Managing Director of Bayer Portugal, Guy Villax, CEO and Board Member of Hovione, as well as the CEO of Fapomed.
More information about the conference and its program at the following addresses:
Full story (Health Cluster Portugal) – Here
Conference Program – Here
Keynote Speaker interview, Manuel Sobrinho Simões to “360º” program of “RTP3”, from minute 11:16 – Here
Interview to newspaper “Público” from Salvador de Mello, president do Health Cluster Portugal – Here
Interview to newspaper “Negócios” from the President of the Portuguese Republic , Marcelo Rebelo de Sousa – Here
Being fully operational since the year 2009, company Fapomed Ukraine has seen its area of intervention, in what Medical Devices of single use concerns, increase and become even more important.
This growth has been recognized not only within the company structure but also by the Ukrainian organizations themselves, be they local or national.
This time, we are pleased to announce the most recent achievement of Fapomed Ukraine, having this obtained a Certificate for Conformity for a greater range of products manufactured internally.
We point that this certificate was issued by the Authorized Body of Ukraine, and is valid for the next 5 years.
To the whole team Fapomed Ukraine and to all involved in this process: Congratulations!
In a period of difficult times, Fapomed honors their commitments and strengthens their civic and social responsibility.
Fapomed is one of the most recent companies allied with the “Compromisso Pagamento Pontual”, an initiative that belongs to the program “AconteSer”, led by ACEGE, in partnership with the CIP, IAPMEI, APIFARMA and more recently with CGD.
With the main objective of “help combat the lack of competitiveness of micro, small and medium enterprises, through the sharing of best practices that enhance corporate action”, Fapomed considers that the payment to the suppliers within the agreed time, is a topic that must be taken very seriously, doing all to not be included in one of the main causes of the “strangulation of enterprise development and, consequently, in the growth of the Portuguese economy”.
Reviewing up in ideals such as quality, responsibility, safety, ethics and commitment, the company does not “runs off” from what considers as the major driver of development and sustainable growth, both personal as well as of the country, choosing then the “high level of requirement” as one of its cornerstones, by which can’t, and will not distance itself.
Respecting equally the Directive 2011/7/EU of the European Parliament and of the Council of 16 February 2011, which establishes measures to combat late payment in commercial transactions, Fapomed puts itself at the forefront of the fight against stagnation development and growth of the Portuguese economy, in the front line in the recovery and job creation, as well in the maintenance of the business environment, and in the growth of the Gross Domestic Product (GDP) of the country.
For more information about the Program click here, and for more information about the Directive click here.
This is the most recent title of an interview given by Fapomed chief executive officer, Miguel Lopes da Cunha to Dinheiro Vivo.
In interview to the suplement, the president of Fapomed, Miguel Lopes da Cunha, starts to contextualize the evolution and growth that the company had, evolving from a traditional textile company, to a surgical gown manufacturer, this in the mid 80’s.
Explaining the “revolutionary” concept wich was the use of non woven fabrics (TNT) “as being the best surgical protection…” the interview continues with the geographic and economis contextualization of the company.
Exporting 80% of its turnover, with factories in Portugal and Ukraine, and laboring exclusively in the area of health, Fapomed is present in 3 main markets: besides the Iberian market, the company works on central Europe and also on the British market.
It have in France and mainly in Germany its own “central market”, supporting this one a weight of 40% of sales”, being followed by Portugal and Spain. Besides this nations, the CEO equally considers important another group of countries, such as “North Africa, neighbouring countries of europe, and also Chile and Republic of Macedonia”.
Holder of own brands, representing “15% of sales – usually outside Europe”, in order to “not compete with our distributors”, Fapomed, through its president, further mentions that they have a intermediate group of surgical kits manufacturers for whom they develop “speciality products”.
When the subject is the future, but always with an eye in the present, Miguel Lopes Da Cunha points out an objective “reach a turnover of 19 million euros for 2020”, remembering in any case that this year Fapomed presents “an interesting growth in the home of double digits. “
Ends his interview making an allusion to the partnership of 30 years with “Caixa geral de Depósitos”, referring it as “if not the first, one of the first financial partners who worked with us,” and with whom still holds today a “close” relationship.
Source: http://www.dinheirovivo.pt/empresas/interior.aspx?content_id=4197686&page=-1
Opens tomorrow in Rivne, the latest Fapomed unit of surgical gowns. This company from Felgueiras invests seven million euros to combat Chinese competition.
Fapomed, a medical device company from Felgueiras, has selected Ukraine by cost factors and geographical advantages. In 2011, the facility will have 400 jobs, invoicing 10 million. In the initial phase will employ 65 workers.
The operation in Ukraine is a response to the Chinese threat and was being prepared for three years, in the aftermath of the competitive start, after the opening of European markets to Asian products. A contract with a multinational pharmaceutical company to supply a considerable amount of surgical gowns was the push that was needed to advance the project. The unit (5000 sqm of covered area) cost 7 million euros.
Diversifying product offering.
In Portugal, Fapomed evolved from gowns to surgical sets to survive and remain competitive. Through new technologies and new products, Fapomed also evolved into an integrated supply kits , backpacks and variable composition sets manufacturer, in order to meet the exact needs of surgical teams of different specialties.
Three years ago, Fapomed adopted a new business paradigm, abandoning the surgical gowns as sales engine, this at a time when multinational companies had diverted their orders to China. “The quality was acceptable and prices unbeatable”; recalls Miguel Lopes da Cunha, president of the company.
However, the manager found that Asian manufacturers were suffering not only from logistics gap but also from responsiveness. There were margin to win the multinationals on the run, combining credibility and fast deliveries, with an approximate price to the Chinese industry. It was the combination of these factors that led the company to Rivne, an average city of Ukraine in the road axis linking the capital Kiev to the border with Poland.
In Portugal, Fapomed employs 190 people in two units and will end 2009 with sales of 7.8 million, a growth of 12%.
